Datavant and UBC Partner to Transform Observational Research and Patient Access for Biopharmaceutical Sponsors

Datavant and United BioSource Corporation (UBC) have joined forces to transform late-phase research and patient access programs for biopharmaceutical sponsors. By combining Datavant’s privacy-first data connectivity with UBC’s expertise in specialty therapies, the partnership introduces two new offerings: Modern Observational Research Study Designs and Enhanced Patient Access Programs. These solutions aim to accelerate evidence generation, improve patient outcomes, and set a new standard for real-world research and access.